Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.31
+0.08 (0.78%)
At close: Feb 3, 2026
SHA:600267 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 546.8 | 601.18 | -93.17 | 488.86 | 486.89 | 417.19 |
Depreciation & Amortization | 1,081 | 1,081 | 1,048 | 1,040 | 951.73 | 874.34 |
Other Amortization | 9.37 | 9.37 | 3.26 | 5.59 | 6.35 | 6.98 |
Loss (Gain) From Sale of Assets | -0.72 | -0.72 | 11.49 | 2.06 | 46.71 | -29.26 |
Asset Writedown & Restructuring Costs | 4.12 | 4.12 | 193.21 | 0.57 | 2.24 | 0.26 |
Loss (Gain) From Sale of Investments | -158.58 | -158.58 | -72.1 | 1.02 | -87.75 | -35.1 |
Provision & Write-off of Bad Debts | 86.75 | 86.75 | 23.48 | -9.53 | 12.7 | -40.81 |
Other Operating Activities | 615.93 | 372.46 | 343.48 | 487.51 | 482.38 | 826.48 |
Change in Accounts Receivable | 277.84 | 277.84 | 118.04 | -398.93 | -31.43 | -71.73 |
Change in Inventory | 69.13 | 69.13 | -170.73 | 19.03 | 398.83 | -678.28 |
Change in Accounts Payable | -241.5 | -241.5 | 167.61 | 362.18 | -585.72 | 300.38 |
Change in Other Net Operating Assets | 5.99 | 5.99 | 9.15 | 46.7 | 20.26 | 26.59 |
Operating Cash Flow | 2,304 | 2,115 | 1,503 | 2,066 | 1,737 | 1,590 |
Operating Cash Flow Growth | 40.71% | 40.72% | -27.26% | 18.96% | 9.24% | 127.61% |
Capital Expenditures | -337.4 | -238.44 | -240.04 | -530.62 | -622.38 | -692.04 |
Sale of Property, Plant & Equipment | 14.14 | 11.23 | 26.46 | 91.62 | 203.67 | 422.14 |
Divestitures | - | - | 23.1 | 43.45 | - | - |
Investment in Securities | -25.78 | -9.23 | -20.56 | -43.06 | -99.93 | 1,181 |
Other Investing Activities | 51.2 | 16.98 | -127.71 | -140.17 | 25.35 | 96.18 |
Investing Cash Flow | -299.17 | -220.8 | -338.71 | -578.78 | -493.28 | 1,008 |
Short-Term Debt Issued | - | 300 | - | 898.8 | 998.55 | 500 |
Long-Term Debt Issued | - | 4,092 | 3,831 | 4,606 | 6,649 | 6,787 |
Total Debt Issued | 2,671 | 4,392 | 3,831 | 5,504 | 7,647 | 7,287 |
Short-Term Debt Repaid | - | -304.04 | -608.54 | -813.27 | -508.63 | -1,328 |
Long-Term Debt Repaid | - | -5,798 | -3,786 | -6,216 | -8,912 | -7,511 |
Total Debt Repaid | -5,448 | -6,103 | -4,395 | -7,030 | -9,421 | -8,839 |
Net Debt Issued (Repaid) | -2,776 | -1,710 | -564.17 | -1,525 | -1,773 | -1,553 |
Issuance of Common Stock | - | - | - | 23.29 | 922.14 | - |
Repurchase of Common Stock | -172.78 | -172.78 | -109.23 | -211.66 | -101.62 | - |
Common Dividends Paid | -359.96 | -148.47 | -356.3 | -381.25 | -417.3 | -461.28 |
Other Financing Activities | 1,503 | -5.25 | 25.49 | 589.57 | -703.79 | -215.4 |
Financing Cash Flow | -1,806 | -2,037 | -1,004 | -1,505 | -2,074 | -2,229 |
Foreign Exchange Rate Adjustments | 1.11 | 3.47 | 4.72 | 6.53 | -0.6 | -20.26 |
Net Cash Flow | 199.21 | -139.74 | 164.47 | -11.92 | -831.37 | 347.88 |
Free Cash Flow | 1,966 | 1,876 | 1,263 | 1,535 | 1,114 | 897.57 |
Free Cash Flow Growth | 28.54% | 48.59% | -17.75% | 37.78% | 24.13% | - |
Free Cash Flow Margin | 19.99% | 19.17% | 12.17% | 12.75% | 9.18% | 7.90% |
Free Cash Flow Per Share | 1.71 | 1.61 | 1.08 | 1.32 | 0.98 | 0.93 |
Cash Interest Paid | - | - | - | - | - | 0.5 |
Cash Income Tax Paid | 766.51 | 626.07 | 643.89 | 666.43 | 667.02 | 293.05 |
Levered Free Cash Flow | 1,525 | 1,459 | 686.12 | 1,115 | 1,176 | 1,411 |
Unlevered Free Cash Flow | 1,594 | 1,557 | 820.75 | 1,292 | 1,392 | 1,674 |
Change in Working Capital | 118.48 | 118.48 | 45.29 | 49.72 | -164.73 | -430.46 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.